companies / cherrybiotech-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-02 json
| total_raised | 2,700,0002.7M | ○ |
|---|---|---|
| founded | null | |
| hq | Paris, France | |
| industry | unknown | |
| stage | null |
3D cell-culture and organoid platforms — organ-on-chip, ready-to-use organoid plates, and standardized spheroid kits. Sold to pharma and CROs replacing animal testing in preclinical work. Microfluidic perfusion gives more in-vivo-like data than static plates.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-09-01 | grant | 2,700,0002.7M | null | ○ |
PHP 8.3, WordPress 7.0, Astra 4.6.13, Magnific Popup 3.9.3, Yoast SEO 27.5, Google Analytics, Google Tag Manager, jQuery Migrate 3.4.1, Elementor 4.0.7, PayU Payment, DoubleClick Floodlight, Cloudflare Browser Insights
| fact | status | src |
|---|---|---|
| Grant, $2.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |